AstraZeneca's revenue from top product Pulmicort 2006-2023
This statistic depicts the revenue from one of pharmaceutical company AstraZeneca's top products, Pulmicort, from 2006 to 2023. In 2023, AstraZeneca's revenue from this product amounted to 713 million U.S. dollars.